Marker: REN92963 |
| Symbol: |
REN92963 |
| Also known as: |
|
| Expected Size: |
270 (bp) |
| Position |
| Map | Chr | Position | Strand | Source |
|---|
Human Genome Assembly HuRef | 19 | 51,299,929 - 51,300,198 | | UniSTS | Human Genome Assembly GRCh37 | 19 | 54,975,887 - 54,976,156 | | UniSTS | Human Celera Assembly | 19 | 52,016,466 - 52,016,735 | | RGD | Human Genome Assembly Build 36 | 19 | 59,667,699 - 59,667,968 | | RGD | Human Cytogenetic Map | 19 | q13.42 | | UniSTS | Human Cytogenetic Map | 19 | q13.4 | | UniSTS |
|
| Is Marker For: |
Genes:
LENG9
CDC42EP5
|
| Model |
|
| 1331657 | COPD9_H | Chronic obstructive pulmonary disease QTL 9 (human) | 1.94 | | Chronic airflow obstruction | post-bronchodilator FEV1 | 19 | 12712793 | 57533128 | Human |
| 1357328 | AASTH24_H | Allergic/atopic asthma related QTL 24 (human) | 1.02 | | Reversible airflow obstruction | post-bronchodilator FEV1 | 19 | 29153142 | 55153142 | Human |
| 1298467 | OSTEAR9_H | Osteoarthritis QTL 9 (human) | 1.83 | | Joint/bone inflammation | hand osteoarthritis | 19 | 31405702 | 57405702 | Human |
| 1357315 | AASTH51_H | Allergic/atopic asthma related QTL 51 (human) | | .0005 | Reversible airflow obstruction | | 19 | 31405702 | 57405702 | Human |
| 1581531 | BP78_H | Blood pressure QTL 78 (human) | 2.3 | .001 | Blood pressure | pulse pressure | 19 | 31405702 | 57405702 | Human |
| 1559403 | SCL118_H | Serum cholesterol level QTL 118 (human) | 3.16 | | Lipid level | triglyceride | 19 | 31405702 | 57405702 | Human |
| 1559124 | SCL23_H | Serum cholesterol level QTL 23 (human) | 3.24 | .000617 | Lipid level | LDL cholesterol | 19 | 31405702 | 57405702 | Human |
| 2302744 | MAMTS26_H | Mammary tumor susceptibility QTL 26 (human) | | .025 | Mammary tumor susceptibility | | 19 | 31405702 | 57405702 | Human |
| 2302745 | MAMTS27_H | Mammary tumor susceptibility QTL 27 (human) | | .034 | Mammary tumor susceptibility | | 19 | 31405702 | 57405702 | Human |
| 2302750 | MAMTS28_H | Mammary tumor susceptibility QTL 28 (human) | | .054 | Mammary tumor susceptibility | | 20 | 31405702 | 57405702 | Human |
| 1559110 | SCL22_H | Serum cholesterol level QTL 22 (human) | 3.59 | .000241 | Lipid level | LDL cholesterol | 19 | 32410844 | 58410844 | Human |
| 1559230 | SAPOE1_H | Serum apolipoprotein E level QTL 1 (human) | 4.2 | | Apolipoprotein level | apolipoprotein E level | 19 | 34098157 | 57667065 | Human |
| 2300240 | PRSTS349_H | Prostate tumor susceptibility QTL 349 (human) | | .0001 | Prostate tumor susceptibility | | 19 | 35332164 | 59110802 | Human |
| 1581530 | BP69_H | Blood pressure QTL 69 (human) | 2.3 | .001 | Blood pressure | pulse pressure | 19 | 37955747 | 59110802 | Human |
| 2314573 | GLUCO60_H | Glucose level QTL 60 (human) | 3.33 | .016545 | Glucose level | fasting | 19 | 40795107 | 59110802 | Human |
| 2314552 | GLUCO56_H | Glucose level QTL 56 (human) | 3.1 | | Glucose level | | 19 | 44667007 | 59110802 | Human |
| 2289232 | BW89_H | Body weight QTL 89 (human) | 3.21 | .091 | Body weight | BMI | 19 | 50955645 | 57019883 | Human |
| 1643251 | BW139_H | Body weight QTL 139 (human) | 1.25 | | Body weight | | 19 | 53783458 | 55546128 | Human |